105 results on '"Reuss, David E"'
Search Results
2. Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions
3. Molecular matched targeted therapies for primary brain tumors—a single center retrospective analysis
4. Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival
5. Oligosarcomas, IDH-mutant are distinct and aggressive
6. Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1
7. Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis
8. Molecular characterization of CNS paragangliomas identifies cauda equina paragangliomas as a distinct tumor entity
9. Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activation
10. Sarcoma classification by DNA methylation profiling
11. Targetable ERBB2 mutations identified in neurofibroma/schwannoma hybrid nerve sheath tumors
12. Infratentorial IDH-mutant astrocytoma is a distinct subtype
13. Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course
14. MYCN amplification drives an aggressive form of spinal ependymoma
15. Array-based DNA-methylation profiling in sarcomas with small blue round cell histology provides valuable diagnostic information
16. Neurofibromin C terminus-specific antibody (clone NFC) is a valuable tool for the identification of NF1-inactivated GISTs
17. Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusions
18. Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1
19. Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA
20. The molecular landscape of glioma in patients with Neurofibromatosis 1
21. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis
22. Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics.
23. Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience
24. Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations
25. DNA methylation-based classification of central nervous system tumours
26. Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities
27. Genome-wide methylation profiling and copy number analysis in atypical fibroxanthomas and pleomorphic dermal sarcomas indicate a similar molecular phenotype
28. Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas
29. Simultaneous Nbs1 and p53 inactivation in neural progenitors triggers high‐grade gliomas.
30. Rapid detection of 2-hydroxyglutarate in frozen sections of IDH mutant tumors by MALDI-TOF mass spectrometry
31. Methylation-based classification of benign and malignant peripheral nerve sheath tumors
32. Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities
33. IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO
34. ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma
35. Neurofibromin specific antibody differentiates malignant peripheral nerve sheath tumors (MPNST) from other spindle cell neoplasms
36. HIP1R and vimentin immunohistochemistry predict 1p/19q status in IDH-mutant glioma.
37. Anaplastic ganglioglioma—A diagnosis comprising several distinct tumour types.
38. Melanotic Tumors of the Nervous System are Characterized by Distinct Mutational, Chromosomal and Epigenomic Profiles
39. Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein
40. Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations
41. First case of disseminated cryptococcosis in a Gorilla gorilla
42. Nuclear relocation of STAT6 reliably predicts NAB2–STAT6 fusion for the diagnosis of solitary fibrous tumour
43. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis
44. Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors.
45. Molecular characterisation of sporadic endolymphatic sac tumours and comparison to von Hippel–Lindau disease‐related tumours.
46. Accurate calling of KIAA1549‐BRAF fusions from DNA of human brain tumours using methylation array‐based copy number and gene panel sequencing data.
47. Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1.
48. A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR.
49. CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas.
50. FGFR1:TACC1 fusion is a frequent event in molecularly defined extraventricular neurocytoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.